SR

Suman Rawat

Active Director Director DIN 01132920
DIN 01132920 First appointment May 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2013
Shareholding value •••• Premium profile

About Suman Rawat

Data last updated:

Suman Rawat is a Director at Liberty Medicare Institute Private Limited (since 2013). The company operates in Healthcare. Liberty Medicare Institute Private Limited reported revenue of ₹2.01 Cr (FY 2025).

DIN 01132920
Primary Designation Director
Industry Healthcare
First Appointment 06 May 2013
Oldest Company Age 27 yrs
Largest company Liberty Medicare Institute Private Limited · ₹2.01 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 May 20131999₹2.01 Cr (FY 2025)Active

Board colleagues of Suman Rawat

Directorship timeline

Open interactive timeline →
Liberty Medicare Institute Private Limited
Premium access

Shareholding and investment profile for Suman Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Rawat

Suman Rawat currently holds 1 directorship: Liberty Medicare Institute Private Limited (Director, since 06 May 2013, revenue ₹2.01 Cr (FY 2025)).

Suman Rawat was first appointed on 06 May 2013 as Director at Liberty Medicare Institute Private Limited.

The current boards of Suman Rawat's companies include Aishwarya Joshi (Liberty Medicare Institute Private Limited), Siddharth Gupta (Liberty Medicare Institute Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available